average bioequivalence [Regulatives / Guidelines]

posted by Mahmoud  – Jordan, 2024-06-24 13:29 (730 d 04:08 ago) – Posting: # 24035
Views: 4,028

Dear All

For statitical anaylsis Semi-Replicated (TRR,RTR,RRT). Some pesrons do the followings:

model= Sequence Period Treatment Sequence*Treatment as fixed effects.

Random : Subject(Sequence) Treatment*Subject(Sequence).

CI for T/R ratio derived using Treatment*Subject(sequence) as the error term.


Is this true under FDA or EMA guidelines.

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
133 visitors (0 registered, 133 guests [including 10 identified bots]).
Forum time: 17:37 CEST (Europe/Vienna)

Scientists often have a naïve faith that
if only they could discover enough facts about a problem,
these facts would somehow arrange themselves
in a compelling and true solution.    Theodosius Dobzhansky

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5